Kinaxis Inc. Reports Third Quarter 2024 Results

  • SaaS revenue grows 16%, adjusted EBITDA1 margin of 25%, annual recurring revenue grows 14%
  • Increases profitability outlook for third consecutive quarter after 32% growth in Adjusted EBITDA
  • Company adds Mark Morgan as president of commercial operations

Kinaxisยฎ (TSX:KXS), a leading provider of supply chain orchestration solutions, reported results for its third quarter ended September 30, 2024. All amounts are in U.S. dollars. All figures are prepared in accordance with IFRS Accounting Standards unless otherwise indicated.

โ€œWe delivered a solid third quarter with continued strength in customer wins, win rates and financial results that allow us to increase our full-year profitability guidance for the third consecutive quarter,โ€ said John Sicard, president and chief executive officer at Kinaxis. โ€œWe recently hit several exciting product milestones, including over 100 customers using our Maestro AI chat agent, and our Enterprise Scheduling product going live at a global consumer products company. I am also particularly proud that Kinaxis was named a 2024 Gartnerยฎ Peer Insightsโ„ข Customersโ€™ Choice for Supply Chain Planning Solutions, the only vendor to earn that distinction in the report, which highlighted that 93% of customers are willing to recommend Kinaxis. This kind of achievement is only possible through outstanding strategy and execution, company-wide.โ€

Q3 2024 Highlights

$ USD thousands, except as otherwise indicated

Q3 2024

Q3 2023

Change

Total Revenue

121,528

108,079

12%

SaaS

78,621

67,940

16%

Subscription term licenses

2,250

2,535

(11)%

Professional services

35,471

32,851

8%

Maintenance and support

5,186

4,753

9%

Gross profit

Margin

76,365

63%

65,336

60%

17%

Profit (loss)

Per diluted share

6,751

$0.23

7,390

$0.25

(9)%

Adjusted EBITDA1

Margin

30,013

25%

22,801

21%

32%

Cash from operating activities

29,945

(1,460)

_

(1)

โ€œAdjusted EBITDAโ€ is a non-IFRS measure and is not a recognized, defined or standardized measure under IFRS. This measure as well as any other non-IFRS financial measures reported by Kinaxis are defined in the โ€œNon-IFRS Measuresโ€ section of this news release.

โ€œIโ€™m pleased with ongoing progress towards our normalized, mid-term 25% adjusted EBITDA margin target, as well as progress on strategic initiatives to capture even more of the $16 billion supply chain management software market,โ€ said Bob Courteau, executive chair at Kinaxis. โ€œThe Board and management have been working very closely over the past six months to review our strategic plan and to assess performance across our operations. That work, with additional input from consultants, has confirmed the strength of Kinaxisโ€™ leading market position and strategy, and highlighted some exciting opportunities ahead, which weโ€™re already acting on.

Courteau concluded: โ€œIโ€™m also thrilled we have added proven industry leader, Mark Morgan, as our new president of commercial operations to drive our go-to-market functions. Incoming leadership, new initiatives, and Kinaxisโ€™ stellar foundation, which John Sicard was instrumental in building, are all key elements to scaling the organization through our next phase of rapid, profitable growth.โ€

Key Performance Indicators

The companyโ€™s Annual Recurring Revenue2 (ARR), which includes subscription amounts related to both SaaS and on-premise contracts, rose 14% to 347 million at the end of the quarter.

$USD millions

Q3 2024

Q3 2023

Change

Annual recurring revenue2

347

304

14%

(2)

Annual Recurring Revenue (ARR) is the total annualized value of recurring subscription amounts (ultimately recognized as SaaS, Subscription term licenses and Maintenance and support revenue) of all subscription contracts at a point in time. Annualized subscription amounts are determined solely by reference to the underlying contracts, normalizing for the varying revenue recognition treatments under IFRS 15 for cloud-based versus on-premise subscription amounts. It excludes one-time fees, such as for non-recurring professional services, and assumes that customers will renew the contractual commitments on a periodic basis as those commitments come up for renewal, unless such renewal is known to be unlikely. We believe that this measure provides a more current indication of our performance in the growth of our subscription business than other metrics.

The nature of the companyโ€™s long-term contracts provides visibility into future, contracted revenue. The following table presents revenue expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) at September 30, 2024.

ย 

$USD millions

Remainder of

2024

ย 

2025

ย 

2026 and later

ย 

Total

SaaS

79.3

253.2

350.3

682.8

Maintenance and support

5.2

15.7

17.2

38.1

Subscription term licenses

โ€”

0.1

0.1

0.2

Total

84.5

269.0

367.6

721.1

Financial Guidance

Kinaxis is updating its fiscal 2024 guidance, as follows:

ย 

FY 2024 Guidance

Total revenue

$483-495 million

SaaS

15-17% growth

Subscription term license

$11-12 million

(Increased)

Adjusted EBITDA1 margin

20-22%

(Increased)

Guidance in this press release is provided to enhance visibility into Kinaxisโ€™ expectations for financial targets for the periods indicated. Please refer to the section regarding forward-looking statements that forms an integral part of this release. This press release along with the financial statements and MD&A for the quarter ended September 30, 2024 are available on Kinaxisโ€™ website and on SEDAR at www.sedar.com.

Conference Call

Kinaxis will host a conference call tomorrow, October 31, 2024, to discuss these results. John Sicard, chief executive officer, Bob Courteau, executive chair, and Blaine Fitzgerald, chief financial officer, will host the call starting at 8:30 a.m. Eastern Time. A question and answer session will follow management's presentation. Investors and participants must register for the call in advance. See registration link below. Please call the conference telephone number fifteen minutes prior to the start time.

DATE:

Thursday, October 31, 2024

TIME:

8:30 a.m. Eastern Time

CALL REGISTRATION:

https://registrations.events/direct/Q4I91416395

WEBCAST

https://events.q4inc.com/attendee/409878969 (available for three months)

About Kinaxis Inc.

Kinaxis is a global leader in modern supply chain orchestration. We serve supply chains and the people who manage them in service of humanity. Our software is trusted by renowned global brands to provide the agility and predictability needed to navigate todayโ€™s volatility and disruption. We combine our patented concurrency technique with a human-centered approach to AI to empower businesses of all sizes to orchestrate their end-to-end supply chain network, from multi-year strategic planning through down-to-the-second execution and last-mile delivery. For more news and information, please visit kinaxis.com or follow us on LinkedIn.

Non-IFRS Measures

This press release makes reference to Adjusted Profit and Adjusted EBITDA, which are non-IFRS financial measures, as well as Adjusted EBITDA margin which expresses Adjusted EBITDA as a percentage of revenue. Adjusted Profit, Adjusted EBITDA and Adjusted EBITDA margin are not recognized, defined or standardized measures under IFRS. We use these measures to provide investors with supplemental information on our operating performance and to highlight trends in our core business that may not otherwise be apparent when relying solely on IFRS financial measures. We believe that securities analysts, investors and other interested parties frequently use non-IFRS measures in the evaluation of issuers. Providing these non-IFRS measures provides useful information because they portray the financial results of the Company before certain expenses that do not impact the ongoing operating decisions taken by management. Management also uses non-IFRS measures in order to facilitate operating performance comparisons from period to period, prepare annual operating budgets and assess our ability to meet our capital expenditure and working capital requirements, and to determine components of employee compensation.

Adjusted Profit represents profit adjusted to exclude the changes in the fair value of contingent consideration, our equity compensation plans, special charges, and non-recurring items. Adjusted EBITDA represents profit adjusted to exclude the change in the fair value of contingent consideration, our equity compensation plans, special charges, non-recurring items, income tax expense, depreciation and amortization, foreign exchange loss (gain) and net finance (income) expense. Adjusted EBITDA margin expresses Adjusted EBITDA as a percentage of revenue. Our definitions of Adjusted Profit, Adjusted EBITDA and Adjusted EBITDA margin will likely differ from those used by other companies (including our peers) and therefore comparability may be limited. Non-IFRS measures should not be considered a substitute for or in isolation from measures prepared in accordance with IFRS. Investors are encouraged to review our financial statements and disclosures in their entirety and are cautioned not to put undue reliance on non-IFRS measures and view them in conjunction with the most comparable IFRS financial measures. Kinaxis has reconciled Adjusted Profit and Adjusted EBITDA to the most comparable IFRS financial measure as follows:

ย 

ย 

Three months ended September 30,

ย 

Nine months ended September 30,

ย 

ย 

2024

ย 

ย 

ย 

2023

ย 

ย 

2024

ย 

ย 

ย 

2023

ย 

ย 

(In thousands of USD)

ย 

(In thousands of USD)

Profit

ย 

6,751

ย 

ย 

ย 

7,390

ย 

ย 

16,372

ย 

ย 

ย 

6,039

ย 

Change in fair value of contingent

ย 

โ€”

ย 

ย 

ย 

(705

)

ย 

โ€”

ย 

ย 

ย 

1,951

ย 

Share-based compensation

ย 

12,929

ย 

ย 

ย 

8,745

ย 

ย 

29,353

ย 

ย 

ย 

26,119

ย 

Special charges1

ย 

3,174

ย 

ย 

ย 

โ€”

ย 

ย 

3,174

ย 

ย 

ย 

โ€”

ย 

Non-recurring item2

ย 

22

ย 

ย 

ย 

โ€”

ย 

ย 

7,320

ย 

ย 

ย 

โ€”

ย 

Adjusted profit

ย 

22,876

ย 

ย 

ย 

15,430

ย 

ย 

56,219

ย 

ย 

ย 

34,109

ย 

Income tax expense

ย 

3,337

ย 

ย 

ย 

3,584

ย 

ย 

8,028

ย 

ย 

ย 

4,885

ย 

Depreciation and amortization

ย 

6,209

ย 

ย 

ย 

6,456

ย 

ย 

18,882

ย 

ย 

ย 

19,860

ย 

Foreign exchange gain (loss)

ย 

411

ย 

ย 

ย 

(76

)

ย 

245

ย 

ย 

ย 

2,033

ย 

Net finance and other income

ย 

(2,820

)

ย 

ย 

(2,593

)

ย 

(8,751

)

ย 

ย 

(5,742

)

ย 

ย 

7,137

ย 

ย 

ย 

7,371

ย 

ย 

18,404

ย 

ย 

ย 

21,036

ย 

Adjusted EBITDA

ย 

30,013

ย 

ย 

ย 

22,801

ย 

ย 

74,623

ย 

ย 

ย 

55,145

ย 

Adjusted EBITDA Margin

ย 

25

%

ย 

ย 

21

%

ย 

21

%

ย 

ย 

18

%

ย 

Note:

(1) Costs associated with business transformation activities, financial advice and shareholder communications.

(2) Costs associated with the restructuring initiative

Forward-Looking Statements

Certain statements in this release constitute forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include statements as to our expectations for:

  • growth of annual total revenue, annual SaaS and Subscription term licenses revenue, and our expectations for Adjusted EBITDA margin achievement, in each case looking forward for our fiscal year ending December 31, 2024;
  • SaaS growth and increased profitability in years beyond 2024; and
  • contracted revenue in future periods, including 2024, 2025 and 2026 and later.

This release also includes forward-looking statements as to Kinaxisโ€™ growth opportunities and the potential benefits of, and markets and demand for, Kinaxisโ€™ products and services. These statements are subject to certain assumptions, risks and uncertainties, including our view of the relative position of Kinaxisโ€™ products and services compared to competitive offerings in the industry.

In particular, our guidance for 2024 annual total revenue, annual SaaS and Subscription term license revenue and annual Adjusted EBITDA margin, as well as our comments on our expectations for SaaS growth and increased profitability in years beyond 2024, are subject to certain assumptions and associated risks including:

  • our ability to win business from new customers and expand business from existing customers;
  • the timing of new customer wins and expansion decisions by our existing customers;
  • maintaining our customer retention levels, and specifically, that customers will renew contractual commitments on a periodic basis as those commitments come up for renewal, at rates consistent with our historic experience;
  • fluctuations in the value of foreign currencies relative to the U.S. Dollar; and
  • with respect to Adjusted EBITDA and profitability, our ability to contain expense levels while expanding our business.

Our guidance and commentary for achievement of contracted revenue in future periods, including in 2024, 2025 and 2026 and later, is based on assumptions and associated risks including:

  • our ability to satisfy material unperformed obligations under our long-term contracts; and
  • the continued financial capacity and creditworthiness of our customers under long-term contracts.

These and other assumptions, risks and uncertainties may cause Kinaxisโ€™ actual results, performance, achievements and developments to differ materially from the results, performance, achievements or developments expressed or implied by forward-looking statements. Material risks and uncertainties relating to our business are described under the headings โ€œForward-Looking Statementsโ€ and โ€œRisks and Uncertaintiesโ€ in our annual MD&A dated February 28, 2024, under the heading โ€œRisk Factorsโ€ in our Annual Information Form dated March 25, 2024 and in our other public documents filed with Canadian securities regulatory authorities, which are available at www.sedarplus.ca. Forward-looking statements are provided to help readers understand managementโ€™s expectations as at the date of this release and may not be suitable for other purposes. Readers are cautioned not to place undue reliance on forward-looking statements. Kinaxis assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law.

SOURCE: Kinaxis Inc.

Kinaxis Inc.

Condensed Consolidated Interim Statements of Financial Position

(Expressed in thousands of USD)

(Unaudited)

ย 

September 30,

2024

December 31,

2023

ย 

ย 

ย 

Assets

ย 

ย 

Current assets:

ย 

ย 

Cash and cash equivalents

$

183,228

$

174,844

Short-term investments

ย 

111,402

ย 

118,118

Trade and other receivables

ย 

137,485

ย 

156,609

Prepaid expenses

ย 

19,355

ย 

14,810

ย 

ย 

451,470

ย 

464,381

Non-current assets:

ย 

ย 

Unbilled receivables

ย 

1,121

ย 

3,155

Other receivables

ย 

925

ย 

972

Prepaid expenses

ย 

2,128

ย 

1,130

Investment tax credits recoverable

ย 

11,271

ย 

8,362

Deferred tax assets

ย 

35,092

ย 

1,184

Contract acquisition costs

ย 

30,186

ย 

27,438

Property and equipment

ย 

33,342

ย 

40,300

Right-of-use assets

ย 

46,055

ย 

47,109

Intangible assets

ย 

19,535

ย 

23,394

Goodwill

ย 

74,997

ย 

74,556

ย 

ย 

254,652

ย 

227,600

ย 

ย 

ย 

ย 

$

706,122

$

691,981

ย 

ย 

ย 

Liabilities and Shareholdersโ€™ Equity

ย 

ย 

Current liabilities:

ย 

ย 

Trade payables and accrued liabilities

ย 

107,149

ย 

39,700

Provisions

ย 

605

ย 

โ€”

Deferred revenue

ย 

126,382

ย 

137,598

Lease obligations

ย 

5,305

ย 

5,805

ย 

ย 

239,441

ย 

183,103

Non-current liabilities:

ย 

ย 

Lease obligations

ย 

45,016

ย 

45,985

Deferred tax liabilities

ย 

6,362

ย 

8,065

ย 

ย 

51,378

ย 

54,050

Shareholdersโ€™ equity:

ย 

ย 

Share capital

ย 

283,605

ย 

307,327

Contributed surplus

ย 

11,322

ย 

44,339

Accumulated other comprehensive income (loss)

ย 

2,202

ย 

1,360

Retained earnings

ย 

118,174

ย 

101,802

ย 

ย 

415,303

ย 

454,828

ย 

ย 

ย 

ย 

$

706,122

$

691,981

ย 

Kinaxis Inc.

Condensed Consolidated Interim Statements of Comprehensive Income

(Expressed in thousands of USD, except share and per share data)

(Unaudited)

ย 

Three months ended September 30,

Nine months ended September 30,

ย 

ย 

2024

ย 

ย 

2023

ย 

ย 

2024

ย 

ย 

2023

ย 

Revenue

$

121,528

ย 

$

108,079

ย 

$

359,176

ย 

$

314,981

ย 

ย 

ย 

ย 

ย 

ย 

Cost of revenue

ย 

45,163

ย 

ย 

42,743

ย 

ย 

139,695

ย 

ย 

124,974

ย 

ย 

ย 

ย 

ย 

ย 

Gross profit

ย 

76,365

ย 

ย 

65,336

ย 

ย 

219,481

ย 

ย 

190,007

ย 

ย 

ย 

ย 

ย 

ย 

Operating expenses:

ย 

ย 

ย 

ย 

Selling and marketing

ย 

22,639

ย 

ย 

23,532

ย 

ย 

74,907

ย 

ย 

76,113

ย 

Research and development

ย 

21,137

ย 

ย 

20,111

ย 

ย 

66,343

ย 

ย 

61,042

ย 

General and administrative

ย 

24,977

ย 

ย 

14,098

ย 

ย 

62,489

ย 

ย 

43,666

ย 

ย 

ย 

68,753

ย 

ย 

57,741

ย 

ย 

203,739

ย 

ย 

180,821

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

7,612

ย 

ย 

7,595

ย 

ย 

15,742

ย 

ย 

9,186

ย 

Other income:

ย 

ย 

ย 

ย 

Foreign exchange gain (loss)

ย 

(411

)

ย 

76

ย 

ย 

(245

)

ย 

(2,033

)

Net finance and other income

ย 

2,887

ย 

ย 

2,598

ย 

ย 

8,903

ย 

ย 

5,722

ย 

Change in fair value of contingent consideration

ย 

โ€”

ย 

ย 

705

ย 

ย 

โ€”

ย 

ย 

(1,951

)

ย 

ย 

2,476

ย 

ย 

3,379

ย 

ย 

8,658

ย 

ย 

1,738

ย 

ย 

ย 

ย 

ย 

ย 

Profit before income taxes

ย 

10,088

ย 

ย 

10,974

ย 

ย 

24,400

ย 

ย 

10,924

ย 

ย 

ย 

ย 

ย 

ย 

Income tax expense

ย 

3,337

ย 

ย 

3,584

ย 

ย 

8,028

ย 

ย 

4,885

ย 

ย 

ย 

ย 

ย 

ย 

Profit

ย 

6,751

ย 

ย 

7,390

ย 

ย 

16,372

ย 

ย 

6,039

ย 

ย 

ย 

ย 

ย 

ย 

Other comprehensive income:

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

Items that are or may be reclassified subsequently to profit (loss):

ย 

ย 

ย 

ย 

Foreign currency translation differences - foreign operations

ย 

3,053

ย 

ย 

(1,757

)

ย 

1,097

ย 

ย 

(1,468

)

Change in valuation of cash flow hedges

ย 

463

ย 

ย 

(594

)

ย 

(255

)

ย 

(364

)

ย 

ย 

3,516

ย 

ย 

(2,351

)

ย 

842

ย 

ย 

(1,832

)

ย 

ย 

ย 

ย 

ย 

Total comprehensive income

$

10,267

ย 

$

5,039

ย 

$

17,214

ย 

$

4,207

ย 

ย 

ย 

ย 

ย 

ย 

Basic earnings per share

$

0.24

ย 

$

0.26

ย 

$

0.58

ย 

$

0.21

ย 

Weighted average number of basic Common Shares

ย 

28,226,878

ย 

ย 

28,428,856

ย 

ย 

28,286,208

ย 

ย 

28,250,462

ย 

Diluted earnings per share

$

0.23

ย 

$

0.25

ย 

$

0.57

ย 

$

0.21

ย 

Weighted average number of diluted Common Shares

ย 

28,812,999

ย 

ย 

29,240,154

ย 

ย 

28,946,558

ย 

ย 

29,119,827

ย 

ย 

Condensed Consolidated Interim Statements of Changes in Shareholdersโ€™ Equity

(Expressed in thousands of USD)

(Unaudited)

ย 

ย 

Accumulated other comprehensive income (loss)

ย 

ย 

Share

capital

Contributed

surplus

Cash flow hedges

Currency translation adjustments

Total

Retained

earnings

Total equity

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

Balance, December 31, 2022

$

244,713

ย 

$

65,129

ย 

$

โ€”

ย 

$

(156

)

$

(156

)

$

91,742

$

401,428

ย 

Profit

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

10,060

ย 

10,060

ย 

Other comprehensive income

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

441

ย 

ย 

1,075

ย 

ย 

1,516

ย 

ย 

โ€”

ย 

1,516

ย 

Total comprehensive income

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

441

ย 

ย 

1,075

ย 

ย 

1,516

ย 

ย 

10,060

ย 

11,576

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

Share options exercised

ย 

41,545

ย 

ย 

(9,991

)

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

31,554

ย 

Restricted share units vested

ย 

10,676

ย 

ย 

(10,676

)

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

โ€”

ย 

Performance share units vested

ย 

2,628

ย 

ย 

(2,628

)

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

โ€”

ย 

Share-based payments

ย 

โ€”

ย 

ย 

35,788

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

35,788

ย 

Shares issued for contingent consideration

ย 

11,097

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

11,097

ย 

Shares repurchased

ย 

(3,332

)

ย 

(33,283

)

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

(36,615

)

Total shareholder transactions

ย 

62,614

ย 

ย 

(20,790

)

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

41,824

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

Balance, December 31, 2023

$

307,327

ย 

$

44,339

ย 

$

441

ย 

$

919

ย 

$

1,360

ย 

$

101,802

$

454,828

ย 

Profit

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

16,372

ย 

16,372

ย 

Other comprehensive loss

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

(255

)

ย 

1,097

ย 

ย 

842

ย 

ย 

โ€”

ย 

842

ย 

Total comprehensive income (loss)

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

(255

)

ย 

1,097

ย 

ย 

842

ย 

ย 

16,372

ย 

17,214

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

Share options exercised

ย 

17,777

ย 

ย 

(4,193

)

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

13,584

ย 

Restricted share units vested

ย 

11,841

ย 

ย 

(11,841

)

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

โ€”

ย 

Deferred share units vested

ย 

1,396

ย 

ย 

(1,396

)

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

โ€”

ย 

Performance share units vested

ย 

5,533

ย 

ย 

(5,533

)

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

โ€”

ย 

Share-based payments

ย 

โ€”

ย 

ย 

29,739

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

29,739

ย 

Shares repurchased

ย 

(38,489

)

ย 

(39,793

)

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

(78,282

)

Obligation related to share repurchases

ย 

(21,780

)

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

(21,780

)

Total shareholder transactions

ย 

(23,722

)

ย 

(33,017

)

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

ย 

โ€”

ย 

(56,739

)

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

Balance, September 30, 2024

$

283,605

ย 

$

11,322

ย 

$

186

ย 

$

2,016

ย 

$

2,202

ย 

$

118,174

$

415,303

ย 

Condensed Consolidated Interim Statements of Cash Flows

(Expressed in thousands of USD)

(Unaudited)

ย 

Three months ended September 30,

Nine months ended September 30,

ย 

ย 

2024

ย 

ย 

2023

ย 

ย 

2024

ย 

ย 

2023

ย 

ย 

ย 

ย 

ย 

ย 

Cash flows from operating activities:

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

Profit

$

6,751

ย 

$

7,390

ย 

$

16,372

ย 

$

6,039

ย 

Items not affecting cash:

ย 

ย 

ย 

ย 

Depreciation of property and equipment and right-of-use assets

ย 

4,870

ย 

ย 

5,126

ย 

ย 

14,888

ย 

ย 

15,787

ย 

Amortization of intangible assets

ย 

1,339

ย 

ย 

1,330

ย 

ย 

3,994

ย 

ย 

4,073

ย 

Share-based payments

ย 

12,929

ย 

ย 

8,745

ย 

ย 

29,353

ย 

ย 

26,119

ย 

Net finance income

ย 

(2,820

)

ย 

(2,593

)

ย 

(8,751

)

ย 

(5,742

)

Change in fair value of contingent consideration

ย 

โ€”

ย 

ย 

(705

)

ย 

โ€”

ย 

ย 

1,951

ย 

Income tax expense

ย 

3,337

ย 

ย 

3,584

ย 

ย 

8,028

ย 

ย 

4,885

ย 

Investment tax credits recoverable

ย 

(900

)

ย 

(825

)

ย 

(2,909

)

ย 

(2,234

)

Change in operating assets and liabilities

ย 

3,511

ย 

ย 

(23,810

)

ย 

9,714

ย 

ย 

736

ย 

Interest received

ย 

2,199

ย 

ย 

2,150

ย 

ย 

10,387

ย 

ย 

5,345

ย 

Interest paid

ย 

(436

)

ย 

(399

)

ย 

(1,277

)

ย 

(1,247

)

Income taxes paid

ย 

(835

)

ย 

(1,453

)

ย 

(4,703

)

ย 

(4,324

)

ย 

ย 

29,945

ย 

ย 

(1,460

)

ย 

75,096

ย 

ย 

51,388

ย 

Cash flows from (used in) investing activities:

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

Purchase of property and equipment and intangible assets

ย 

(163

)

ย 

(378

)

ย 

(2,247

)

ย 

(2,010

)

Purchase of short-term investments

ย 

(21,891

)

ย 

(72,053

)

ย 

(238,760

)

ย 

(172,724

)

Redemption of short-term investments

ย 

46,722

ย 

ย 

35,005

ย 

ย 

245,117

ย 

ย 

95,165

ย 

ย 

ย 

24,668

ย 

ย 

(37,426

)

ย 

4,110

ย 

ย 

(79,569

)

ย 

ย 

ย 

ย 

ย 

Cash flows from (used in) financing activities:

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

Payment of lease obligations

ย 

(1,834

)

ย 

(1,689

)

ย 

(5,360

)

ย 

(5,245

)

Repurchase of shares

ย 

(20,875

)

ย 

โ€”

ย 

ย 

(78,282

)

ย 

โ€”

ย 

Proceeds from exercise of stock options

ย 

2,276

ย 

ย 

1,071

ย 

ย 

13,584

ย 

ย 

20,715

ย 

ย 

ย 

(20,433

)

ย 

(618

)

ย 

(70,058

)

ย 

15,470

ย 

ย 

ย 

ย 

ย 

ย 

Increase (decrease) in cash and cash equivalents

ย 

34,180

ย 

ย 

(39,504

)

ย 

9,148

ย 

ย 

(12,711

)

ย 

ย 

ย 

ย 

ย 

Cash and cash equivalents, beginning of period

ย 

147,155

ย 

ย 

201,608

ย 

ย 

174,844

ย 

ย 

175,347

ย 

ย 

ย 

ย 

ย 

ย 

Effects of exchange rates on cash and cash equivalents

$

1,893

ย 

$

(1,801

)

ย 

(764

)

ย 

(2,333

)

ย 

ย 

ย 

ย 

ย 

Cash and cash equivalents, end of period

ย 

183,228

ย 

ย 

160,303

ย 

$

183,228

ย 

$

160,303

ย 

ย 

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.00
+2.08 (1.00%)
AAPL  264.18
-8.77 (-3.21%)
AMD  213.84
+0.00 (0.00%)
BAC  49.83
-2.47 (-4.72%)
GOOG  311.43
+4.28 (1.39%)
META  648.18
-8.83 (-1.34%)
MSFT  389.00
+0.00 (0.00%)
NVDA  177.19
-7.70 (-4.16%)
ORCL  145.40
-4.91 (-3.27%)
TSLA  402.51
-6.07 (-1.49%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Gift this article